Multiscale modeling of monoclonal antibody (mAb) production and glycosylation in a CHO cell culture process by Luo, Yu et al.
 Poster Number 28 
MULTISCALE MODELING OF MONOCLONAL ANTIBODY (MAB) PRODUCTION AND GLYCOSYLATION IN 
A CHO CELL CULTURE PROCESS 
 
Yu Luo*, Department of Chemical and Biomolecular Engineering, University of Delaware 
yuluo@udel.edu  
J. Vincent Price*, Janssen Research and Development 
jprice35@its.jnj.com 
Robert J. Lovelett, Department of Chemical and Biomolecular Engineering, University of Delaware 
Devesh Radhakrishnan, Department of Chemical and Biomolecular Engineering, University of Delaware 
Kristopher Barnthouse, Janssen Research and Development 
Gene Schaefer, Janssen Research and Development 
John Cunningham, Janssen Research and Development 
Kelvin H. Lee, Department of Chemical and Biomolecular Engineering, University of Delaware 
Raghu Shivappa, Janssen Research and Development 
Babatunde A. Ogunnaike, Department of Chemical and Biomolecular Engineering, University of Delaware 
 
 
Key Words: multiscale modeling, glycosylation, monoclonal antibodies, parameter estimation 
 
The production of recombinant therapeutic monoclonal antibodies (mAbs) using cultured mammalian cells 
accounts for approximately $80 billion in global sales annually. These antibodies are often produced using 
Chinese hamster ovary (CHO) cell lines that execute the necessary post-translational modifications (e.g., 
glycosylation) for the drug to be therapeutically efficacious. Glycosylation is an intracellular, enzymatic process 
by which glycans (i.e., sugar molecules) are attached to a specific location on the antibody. The structure of the 
glycans attached to the mAb affects the therapeutic function of the molecule, making glycan distribution a critical 
quality attribute. Consequently, the ability to predict how variations in process parameters and/or media 
components affect both product formation and glycosylation is important from both a process development and 
process control viewpoint. A multiscale, mathematical model describing CHO cell growth and antibody 
production was developed in MATLAB to provide a quantitative understanding of how to manipulate a cell 
culture process to improve antibody titer and control glycosylation effectively. At the macro (bioreactor) scale, 
the model uses Monod growth kinetics to describe cell growth, nutrient/metabolite concentrations, and mAb 
production; at the micro scale, the glycosylation process in the Golgi apparatus is modeled using a glycosylation 
reaction network governed by Michaelis-Menten enzyme kinetics. Although both macro and micro scale 
processes are dynamic, disparate time scales makes it possible to solve the (fast) glycosylation model as a 
static function of the (slowly changing) macro scale state variables. In this multidisciplinary study, we will present 
a design of experiments approach for (1) identifying significant factors affecting glycosylation—including 
concentrations of asparagine, glutamine, and copper in the media, and (2) using these factors as macro scale 
“inputs” to the micro scale model. Model predictions are validated against an independent data set from a 
representative industrial mammalian cell culture process. Ultimately, the models we discuss will be valuable for 
biopharmaceutical process development and model-based control system design. 
 
